Genmab
GMAB
GMAB
228 hedge funds and large institutions have $1.27B invested in Genmab in 2024 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 75 increasing their positions, 75 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 75
1% less capital invested
Capital invested by funds: $1.28B → $1.27B (-$11.8M)
Holders
228
Holding in Top 10
–
Calls
$3.44M
Puts
$872K
Top Buyers
| 1 | +$41.7M | |
| 2 | +$37.4M | |
| 3 | +$33.8M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$28.8M |
| 5 |
Morgan Stanley
New York
|
+$24.3M |
Top Sellers
| 1 | -$56.2M | |
| 2 | -$38.4M | |
| 3 | -$17.2M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$12.1M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$9.89M |